Active Clothing Reports Robust Growth With 40 Percent Topline And 73 Percent Net Profit Increase In FY25

Active Clothing Co. Limited has announced strong financial results for FY25, showcasing significant growth in revenue and profitability. The company’s strategic focus on innovation, operational efficiency, and engagement with global fashion brands has contributed to its impressive performance.  

Key Highlights Of Active Clothing’s FY25 Financial Results  
- Total income for FY25 reached ₹297.12 crore, reflecting a year-on-year growth of 39.72 percent  
- EBITDA stood at ₹28.49 crore, marking a 34.24 percent increase compared to the previous fiscal year  
- Profit after tax (PAT) surged to ₹8.45 crore, recording a 73.73 percent year-on-year growth  
- Diluted earnings per share (EPS) rose to ₹5.45, showing a 74.12 percent increase  

Quarterly Performance And Growth Trends  
Active Clothing’s Q4 FY25 results further highlight the company’s strong financial trajectory. The total income for the quarter stood at ₹68.76 crore, reflecting an 81.23 percent year-on-year growth. EBITDA for the quarter reached ₹5.60 crore, while PAT increased to ₹1.63 crore, marking a 21.52 percent rise.  

Strategic Initiatives Driving Growth  
The company attributes its success to continuous investments in smart manufacturing, digital solutions, and new product categories. Its integrated design-to-shelf platform has enabled faster turnaround times and greater value for global fashion partners. Active Clothing remains committed to sustaining its growth momentum through innovation and operational excellence.  

Future Outlook And Industry Impact  
- Analysts anticipate continued expansion as Active Clothing strengthens its capabilities in design, manufacturing, and technology  
- The company’s focus on sustainable fashion and digital transformation is expected to enhance its competitive edge in the global apparel market  
- Active Clothing’s financial performance reinforces its position as a key player in India’s fashion and textile industry  

Sources: ThePrint, MarketsMojo.
 

‹›

STORIES YOU MAY LIKE

RBI’s 6-Day Variable Rate Repo Auction: Bids Fall Short At ₹599.67 Billion Against ₹1 Trillion

Aurobindo Pharma’s CuraTeQ Hits Major Milestone With Denosumab Biosimilar Phase 3 Success

₹1.41 Billion Tax Notice For Mukka Proteins—Company Assures No Material Impact

‹›